Nick Rose

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery. In this issue: 1) University of California, San Diego (UCSD)/Salk Institute for Biological Studies/La Jolla Institute for Allergy and Immunology 2) University of Michigan's Comprehensive Cancer Center/Stanford University School of Medicine 3) University of Rochester 4) Yale School of Medicine 5) University of Illinois at Chicago

Successful research into new therapies for cancer requires a ready supply of patients willing to participate in clinical trials, and physicians and other health care professionals who will refer their patients to the appropriate studies. In each issue, we provide up-to-date information on current or recently announced phase I, II, and III clinical trials focused on biotech-related oncology pharmaceutical therapies.